430
Views
29
CrossRef citations to date
0
Altmetric
Research Papers

Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: A preliminary analysis of goals and outcomes

&
Pages 220-226 | Accepted 01 Jan 2008, Published online: 07 Jul 2009

References

  • van Kuijk A A, Geurts A CH, Bevaart B JW, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature. J Rehabil Med 2002; 34(2)51–61
  • Bakheit A M, Sawyer J. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait – a pilot study. Disabil Rehabil 2002; 24(10)519–522
  • Bhakta B B, Cozens J A, Chamberlain M A, Bamford J M. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial. J Neurol, Neurosurg Psychiatry 2000; 69(2)217–221
  • Bhakta B B, Cozens J A, Bamford J M, Chamberlain M A. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol, Neurosurg Psychiatry 1996; 61(1)30–35
  • Brashear A, Gordon M F, Elovic E, Kassicieh V D, Marciniak C, Do M, Lee C H, Jenkins S, Turkel C, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke [comment]. New Eng J Med 2002; 347(6)395–400
  • Hesse S, Jahnke M T, Luecke D, Mauritz K H. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995; 201(1)37–40
  • Richardson D, Edwards S, Sheean G L, Greenwood R J, Thompson A J. The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: A case report. Clin Rehabil 1997; 11(4)288–292
  • Rodriquez A A, McGinn M, Chappell R. Botulinum toxin injection of spastic finger flexors in hemiplegic patients. Am J Phys Med Rehabil 2000; 79(1)44–47
  • Simpson D M, Alexander D N, O'Brien C F, Tagliati M, Aswad A S, Leon J M, Gibson J, Mordaunt J M, Monaghan E P. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996; 46(5)1306–1310
  • Smith S J, Ellis E, White S, Moore A P. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000; 14(1)5–13
  • Turner Stokes L, Jackson D. Shoulder pain after stroke: A review of the evidence base to inform the development of an integrated care pathway. Clin Rehabil 2002; 16(3)276–298
  • Sheean G L. Botulinum treatment of spasticity: Why is it difficult to show a functional benefit?. Trauma Rehabil 2001; 771–776
  • Royal College of Physicians, Guidelines for the use of botulinum toxin (BTX) in the management of spasticity in adults. Clinical Effectiveness and Evaluation Unit; 2002
  • Wade D T, Collin C. The Barthel ADL index: A standard measure of physical disability. Int Disabil Studies 1988; 10: 64–67
  • Ashford S, Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 2006; 11(1)24–34
  • Rushton P W, Miller W C. Goal attainment scaling in the rehabilitation of patients with lower-extremity amputations: A pilot study. Arch Phys Med Rehabil 2002; 83(6)771–775
  • Kiresuk T, Sherman R. Goal attainment scaling: A general method of evaluating comprehensive mental health programmes. Community Mental Health J 1968; 4: 443–453
  • Bohannon R W, Smith M B. Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207
  • Turner-Stokes L, Jackson D. Assessment of shoulder pain in hemiplegia: Sensitivity of the ShoulderQ. Disabil Rehabil 2006; 28(6)389–395
  • Jackson D, Horn S, Kersten P, Turner-Stokes L. A pictorial scale of pain intensity (SPIN) for patients with communication impairments. 2006; 13(10)457–463
  • Francis H P, Jackson D, Turner-Stokes L, Khatoon A, Stern H, Knight L, O'Connell A. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol, Neurosurg Psychiatry 2004; 75(11)1547–1551
  • Bhakta B BC, Chamberlain J A, Bamford J M. Randomized double-blind placebo-controlled trial of botulinum toxin treatment on the disabling effects of severe arm spasticity in stroke. Clin Rehabil 2000; 14: 213

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.